Cannabis might be getting cheaper in Brampton thanks to a new pilot project.
CannabCo Pharmaceutical Corp. (CannabCo) is a Canadian company located in Brampton. They have recently announced an agreement with an undisclosed technology provider to deploy an advanced cannabis cultivation system.
The new system can produce cannabis at record yields and a cost of under $.50 per gram indoors. Once the company receives its license from Health Canada, CannabCo will have exclusive rights to deploy the cultivation technology for its Canadian operations.
The new system, Phoenix, will constantly harvest the plants. It has been designed to produce a record yield of cannabis in a given space with a greatly reduced cultivation cost.
- Peel Police are investigating attempted carjacking incident in Brampton
- All COVID-19 outbreaks declared at Brampton long-term care facilities from Jan 11 to 17
- New COVID-19 case reported at Fortinos in Brampton
“We’ve observed and given input to the evolution of the system over the last 4 years and are constantly amazed at the yield, and consistency of the results,” said CannabCo’s Chief Operating Officer Mark Novak. “We are proud to have been part of its evolution and are very excited at the prospect of using the technology.”
Phoenix will provide product consistency and repeatability for Pharmaceutical grade supply and “top-shelf” product quality.
“Phoenix has a number of advantages over current traditional cultivation methods,” said Novak. “The market will demand pharma quality inputs and flower free from various pesticides. Customers always want a top-shelf product… and Phoenix has been designed to meet and exceed those expectations.”
CannabCo is currently constructing its pilot facility in Brampton and has received a Confirmation of Readiness notification from Health Canada for their pending cannabis license.
The company intends to deploy Phoenix in a much larger expansion facility in 2020.
“The deployment of Phoenix will be disruptive in the industry and lower the bar dramatically for indoor production costs while raising the bar for quality. Quality has been something sorely lacking from many growers and desperately needed in the Canadian market. Over the years we’ve seen the grows, and been provided consistent test results from cannabis cultivated using Phoenix and the results have been stellar in comparison to the control tests both in yield and final quality,” said Mark Pellicane, CEO of CannabCo.